195 related articles for article (PubMed ID: 36011352)
1. Indoloquinoline-Mediated Targeted Downregulation of KRAS through Selective Stabilization of the Mid-Promoter G-Quadruplex Structure.
Psaras AM; Carty RK; Miller JT; Tumey LN; Brooks TA
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011352
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a new G-quadruplex forming region within the kRAS promoter as a transcriptional regulator.
Morgan RK; Batra H; Gaerig VC; Hockings J; Brooks TA
Biochim Biophys Acta; 2016 Feb; 1859(2):235-45. PubMed ID: 26597160
[TBL] [Abstract][Full Text] [Related]
3. Targeting KRAS Regulation with PolyPurine Reverse Hoogsteen Oligonucleotides.
Psaras AM; Valiuska S; Noé V; Ciudad CJ; Brooks TA
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216221
[TBL] [Abstract][Full Text] [Related]
4. Insight into the Complexity of the i-Motif and G-Quadruplex DNA Structures Formed in the KRAS Promoter and Subsequent Drug-Induced Gene Repression.
Kaiser CE; Van Ert NA; Agrawal P; Chawla R; Yang D; Hurley LH
J Am Chem Soc; 2017 Jun; 139(25):8522-8536. PubMed ID: 28570076
[TBL] [Abstract][Full Text] [Related]
5. High-resolution three-dimensional NMR structure of the
Kerkour A; Marquevielle J; Ivashchenko S; Yatsunyk LA; Mergny JL; Salgado GF
J Biol Chem; 2017 May; 292(19):8082-8091. PubMed ID: 28330874
[TBL] [Abstract][Full Text] [Related]
6. High resolution crystal structure of a KRAS promoter G-quadruplex reveals a dimer with extensive poly-A π-stacking interactions for small-molecule recognition.
Ou A; Schmidberger JW; Wilson KA; Evans CW; Hargreaves JA; Grigg M; O'Mara ML; Iyer KS; Bond CS; Smith NM
Nucleic Acids Res; 2020 Jun; 48(10):5766-5776. PubMed ID: 32313953
[TBL] [Abstract][Full Text] [Related]
7. G4 DNA in ras genes and its potential in cancer therapy.
Cogoi S; Xodo LE
Biochim Biophys Acta; 2016 Apr; 1859(4):663-74. PubMed ID: 26855080
[TBL] [Abstract][Full Text] [Related]
8.
D'Aria F; Pagano B; Petraccone L; Giancola C
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466280
[TBL] [Abstract][Full Text] [Related]
9. Critical role of hnRNP A1 in activating KRAS transcription in pancreatic cancer cells: A molecular mechanism involving G4 DNA.
Cogoi S; Rapozzi V; Cauci S; Xodo LE
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1389-1398. PubMed ID: 27888145
[TBL] [Abstract][Full Text] [Related]
10. The human AP-endonuclease 1 (APE1) is a DNA G-quadruplex structure binding protein and regulates KRAS expression in pancreatic ductal adenocarcinoma cells.
Pramanik S; Chen Y; Song H; Khutsishvili I; Marky LA; Ray S; Natarajan A; Singh PK; Bhakat KK
Nucleic Acids Res; 2022 Apr; 50(6):3394-3412. PubMed ID: 35286386
[TBL] [Abstract][Full Text] [Related]
11. Porphyrins to restrict progression of pancreatic cancer by stabilizing KRAS G-quadruplex: In silico, in vitro and in vivo validation of anticancer strategy.
Pattanayak R; Barua A; Das A; Chatterjee T; Pathak A; Choudhury P; Sen S; Saha P; Bhattacharyya M
Eur J Pharm Sci; 2018 Dec; 125():39-53. PubMed ID: 30223034
[TBL] [Abstract][Full Text] [Related]
12. Protein hnRNPA1 binds to a critical G-rich element of KRAS and unwinds G-quadruplex structures: implications in transcription.
Xodo L; Paramasivam M; Membrino A; Cogoi S
Nucleic Acids Symp Ser (Oxf); 2008; (52):159-60. PubMed ID: 18776302
[TBL] [Abstract][Full Text] [Related]
13.
Marquevielle J; Kumar MVV; Mergny JL; Salgado GF
Biomol NMR Assign; 2018 Apr; 12(1):123-127. PubMed ID: 29189986
[TBL] [Abstract][Full Text] [Related]
14. G-quadruplex structures in the human genome as novel therapeutic targets.
Bidzinska J; Cimino-Reale G; Zaffaroni N; Folini M
Molecules; 2013 Oct; 18(10):12368-95. PubMed ID: 24108400
[TBL] [Abstract][Full Text] [Related]
15. Spectroscopic investigation of the interaction between G-quadruplex of KRAS promoter sequence and three isoquinoline alkaloids.
Wen LN; Xie MX
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():287-296. PubMed ID: 27565766
[TBL] [Abstract][Full Text] [Related]
16. Selective binding of a bioactive porphyrin-based photosensitizer to the G-quadruplex from the KRAS oncogene promoter.
Caterino M; D'Aria F; Kustov AV; Belykh DV; Khudyaeva IS; Starseva OM; Berezin DB; Pylina YI; Usacheva T; Amato J; Giancola C
Int J Biol Macromol; 2020 Feb; 145():244-251. PubMed ID: 31870869
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains.
Lavrado J; Borralho PM; Ohnmacht SA; Castro RE; Rodrigues CM; Moreira R; dos Santos DJ; Neidle S; Paulo A
ChemMedChem; 2013 Oct; 8(10):1648-61. PubMed ID: 23960016
[TBL] [Abstract][Full Text] [Related]
18. KRAS promoter oligonucleotide with decoy activity dimerizes into a unique topology consisting of two G-quadruplex units.
Podbevšek P; Plavec J
Nucleic Acids Res; 2016 Jan; 44(2):917-25. PubMed ID: 26656490
[TBL] [Abstract][Full Text] [Related]
19. Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to berberine and coptisine.
Wang KB; Liu Y; Li J; Xiao C; Wang Y; Gu W; Li Y; Xia YZ; Yan T; Yang MH; Kong LY
Nat Commun; 2022 Oct; 13(1):6016. PubMed ID: 36224201
[TBL] [Abstract][Full Text] [Related]
20. The KRAS promoter responds to Myc-associated zinc finger and poly(ADP-ribose) polymerase 1 proteins, which recognize a critical quadruplex-forming GA-element.
Cogoi S; Paramasivam M; Membrino A; Yokoyama KK; Xodo LE
J Biol Chem; 2010 Jul; 285(29):22003-16. PubMed ID: 20457603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
